Abstract
Previous studies of human hepatic encephalopathy (HE) have shown decreased levels of glial fibrillary acidic protein (GFAP) in Alzheimer type II astrocytes. In view of the important role of ammonia in the pathogenesis of HE, we carried out immunocytochemical and enzyme-linked immunosorbent assay (ELISA) studies on the effect of ammonium chloride (10 mM) on GFAP content in primary astrocyte cultures. There was a 39% loss of GFAP after a four day treatment. There was no fall in total cell protein. Potential mechanisms for this apparent selective loss of GFAP are discussed.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 399-405 |
| Number of pages | 7 |
| Journal | Journal of Neuropathology and Experimental Neurology |
| Volume | 49 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jul 1990 |
Keywords
- Ammonia
- Astrocytes
- Encephalopathy, hepatic
- Glial fibrillary acidic protein
ASJC Scopus subject areas
- Pathology and Forensic Medicine
- Neuroscience(all)
Fingerprint Dive into the research topics of 'Ammonia induced decrease in glial fibrillary acidic protein in cultured astrocytes'. Together they form a unique fingerprint.
Cite this
Norenberg, M. D., Neary, J. T., Norenberg, L. O. B., & McCarthy, M. (1990). Ammonia induced decrease in glial fibrillary acidic protein in cultured astrocytes. Journal of Neuropathology and Experimental Neurology, 49(4), 399-405. https://doi.org/10.1097/00005072-199007000-00004